简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2021-09-24 16:49 Rhizen Pharmaceuticals AG Announces First Patient Dosed in a Phase 2 Study of RP7214 in Covid-19 Patients
2021-09-24 14:40 Davos Alzheimer's Collaborative, World Economic Forum Announce Major Milestones in the Global Fight Against Alzheimer’s Disease
2021-09-24 11:10 NeuroVasc Announces First Patient Enrolled in ENVI™-SR Mechanical Thrombectomy System Clinical Trial in China
2021-09-24 11:06 IHMA Opens Microbiology Reference Laboratory in Shanghai, China to Further Support Global Anti-Infective Product Discovery and Development
2021-09-24 10:12 Biovectra Enhances Manufacturing Capacity and Flexibility with ABEC’s CSR® Large-Scale, Single-Use Microbial Fermentation Technology
2021-09-23 20:46 Organon Aims to Ignite Worldwide Conversation Around Unplanned Pregnancy
2021-09-23 16:44 Clinical Investigation Shows Herb-Pharma's ViroStop Spray Effective in Reducing Impact of Covid-19
2021-09-23 15:12 EngageSmart Announces Pricing of Initial Public Offering
2021-09-23 13:36 Galderma Announces Exclusive Agreement With Sofregen to Develop the Next Generation of Biostimulator Fillers Using Silk-Based Technology
2021-09-23 11:51 ABEC Sets Another Industry Benchmark in Single-Use Bioprocessing
2021-09-22 18:26 Celltrion’s monoclonal antibody treatment for COVID-19, regdanvimab (CT-P59) becomes the first authorized COVID-19 treatment approved from the Korean Ministry of Food and Drug Safety (MFDS)
2021-09-22 10:08 Boehringer Ingelheim Acquires Abexxa Biologics to Further Expand its Research Efforts in Cancer Immunology and Novel Immunotherapeutic Approaches
2021-09-22 10:06 Hologic Releases Results of Inaugural Global Women’s Health Index – First Study Representing the Health of 2.5 Billion Women and Girls
2021-09-17 18:55 Masimo Launches Single-patient-use rainbow® SuperSensor™
2021-09-17 18:53 Takeda’s EXKIVITY™ (mobocertinib) Approved by U.S. FDA as the First Oral Therapy Specifically Designed for Patients with EGFR Exon20 Insertion+ NSCLC
2021-09-17 15:47 Virpax® Pharmaceuticals Announces Closing of $40 Million Public Offering of Common Stock
2021-09-17 09:08 Boehringer Ingelheim Enters Clinical Collaboration with Amgen to Study BI 1701963, a SOS1::pan-KRAS Inhibitor, in Combination with LUMAKRAS™ (sotorasib), a KRASG12C Inhibitor
2021-09-16 19:16 Philip Morris International Announces Unconditional Offer for Vectura Group PLC
2021-09-16 16:30 Trividia Health Announces Jonathan Chapman as President and Chief Executive Officer
2021-09-16 13:51 Vifor Pharma and Travere Therapeutics announce licensing agreement for the commercialization of sparsentan in Europe, Australia and New Zealand

Business Wire Weibo

Press Releases

Latest Releases